Advertisement
Screener

GINKGO BIOWORKS HOLDINGS, INC. (DNA) Income (Loss) from Equity Method Investments

1.6 / 5 stars · 16/49 Roast Me

GINKGO BIOWORKS HOLDINGS, INC. Income (Loss) from Equity Method Investments

GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Income (Loss) from Equity Method Investments of -$4.67 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Other Income

us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-06

  • GINKGO BIOWORKS HOLDINGS, INC. income (loss) from equity method investments for the quarter ending 2026-06-30 was -$4.67M.
  • GINKGO BIOWORKS HOLDINGS, INC. income (loss) from equity method investments for the quarter ending 2025-06-30 was $0.00.
  • GINKGO BIOWORKS HOLDINGS, INC. income (loss) from equity method investments for the quarter ending 2024-12-31 was $0.00.
  • GINKGO BIOWORKS HOLDINGS, INC. income (loss) from equity method investments for the quarter ending 2024-09-30 was $0.00.
  • GINKGO BIOWORKS HOLDINGS, INC. income (loss) from equity method investments for fiscal 2025 was $0.00.
  • GINKGO BIOWORKS HOLDINGS, INC. income (loss) from equity method investments for fiscal 2024 was $0.00.
  • GINKGO BIOWORKS HOLDINGS, INC. income (loss) from equity method investments for fiscal 2023 was -$2.63M.
  • GINKGO BIOWORKS HOLDINGS, INC. income (loss) from equity method investments for fiscal 2022 was -$43.76M.
Period endIncome (Loss) from Equity Method Investments 3 monthIncome (Loss) from Equity Method Investments 6 monthIncome (Loss) from Equity Method Investments 9 monthIncome (Loss) from Equity Method Investments 12 monthIncome (Loss) from Equity Method Investments 12 month as first filed
2026-06-30-$4.67M
10-Q · filed 2026-08-06
-$4.67M
10-Q · filed 2026-08-06
2025-12-31$0.00
10-K · filed 2026-02-26
2025-06-30$0.00
10-Q · filed 2026-08-06
$0.00
10-Q · filed 2026-08-06
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
10-K · filed 2026-02-26
2024-09-30$0.00
10-Q · filed 2024-11-12
$0.00
derived: sum of 2 quarters · filed 2024-11-12
$0.00
10-Q · filed 2024-11-12
-$1.12M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$0.00
10-Q · filed 2024-08-08
$0.00
10-Q · filed 2024-08-08
-$1.12M
derived: sum of 3 quarters · filed 2026-02-26
-$1.12M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$0.00
10-Q · filed 2024-05-09
-$1.12M
derived: sum of 2 quarters · filed 2026-02-26
-$1.12M
derived: sum of 3 quarters · filed 2026-02-26
-$1.19M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$1.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$1.12M
derived: sum of 2 quarters · filed 2026-02-26
-$1.19M
derived: sum of 3 quarters · filed 2026-02-26
-$2.63M
10-K · filed 2026-02-26
2023-09-30$0.00
10-Q · filed 2024-11-12
-$67.00K
derived: sum of 2 quarters · filed 2024-11-12
-$1.52M
10-Q · filed 2024-11-12
$8.49M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30-$67.00K
10-Q · filed 2024-08-08
-$1.52M
10-Q · filed 2024-08-08
$8.49M
derived: sum of 3 quarters · filed 2025-02-25
-$14.22M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31-$1.45M
10-Q · filed 2024-05-09
$8.55M
derived: sum of 2 quarters · filed 2025-02-25
-$14.16M
derived: sum of 3 quarters · filed 2025-02-25
-$24.32M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$10.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$12.71M
derived: sum of 2 quarters · filed 2025-02-25
-$22.87M
derived: sum of 3 quarters · filed 2025-02-25
-$43.76M
10-K · filed 2025-02-25
2022-09-30-$22.71M
10-Q · filed 2023-11-08
-$32.88M
derived: sum of 2 quarters · filed 2023-11-08
-$53.76M
10-Q · filed 2023-11-08
-$58.43M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$10.17M
10-Q · filed 2023-08-09
-$31.05M
10-Q · filed 2023-08-09
-$35.72M
derived: sum of 3 quarters · filed 2024-02-29
-$75.37M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$20.89M
10-Q · filed 2023-05-10
-$25.55M
derived: sum of 2 quarters · filed 2024-02-29
-$65.20M
derived: sum of 3 quarters · filed 2024-02-29
-$69.55M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$4.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$44.31M
derived: sum of 2 quarters · filed 2024-02-29
-$48.66M
derived: sum of 3 quarters · filed 2024-02-29
-$77.28M
10-K · filed 2024-02-29
2021-09-30-$39.65M
10-Q · filed 2022-11-14
-$44.00M
derived: sum of 2 quarters · filed 2022-11-14
-$72.62M
10-Q · filed 2022-11-14
-$70.87M
derived: sum of 4 quarters · filed 2023-03-13
2021-06-30-$4.35M
10-Q · filed 2022-08-15
-$32.97M
10-Q · filed 2022-08-15
-$31.21M
derived: sum of 3 quarters · filed 2023-03-13
-$31.45M
derived: sum of 4 quarters · filed 2023-03-13
2021-03-31-$28.62M
10-Q · filed 2022-05-16
-$26.87M
derived: sum of 2 quarters · filed 2023-03-13
-$27.11M
derived: sum of 3 quarters · filed 2023-03-13
2020-12-31$1.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13
$1.52M
derived: sum of 2 quarters · filed 2023-03-13
-$396.00K
10-K · filed 2023-03-13
-$3.06M
8-K · filed 2021-11-24
2020-09-30-$237.00K
10-Q · filed 2021-11-15
-$2.15M
10-Q · filed 2021-11-15
2019-12-31-$27.53M
10-K · filed 2022-03-29
-$46.94M
8-K · filed 2021-11-24